Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release
Press release |
12 March 2020
COVID-19
Italy

MSF starts COVID-19 response activities in four northern Italian hospitals

The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece. Photograph by Sophia Apostolia
Press release
Press release |
29 January 2020
Vaccines

Global vaccines community must urgently support rollout of new more affordable pneumonia vaccine

4 min
MSF protests at Wall Street after J&J announces 2019 sales increase MSF
Press release
Press release |
22 January 2020
Tuberculosis

As J&J release earnings, MSF protests price of lifesaving TB drug

4 min
Gavi, the Vaccine Alliance, 20 year anniversary
Press release
Press release |
21 January 2020
Vaccines

As Gavi turns 20, MSF urges the vaccine alliance to protect more kids from pneumonia

4 min
•	MSF medical doctor, Stefanos Tsallas vaccinates a child from refugee camp against pneumonia
Press release
Press release |
20 December 2019
Vaccines

First alternative pneumonia vaccine breaks Pfizer and GSK’s decades-long stranglehold, promising more children protected against biggest childhood killer

4 min
The first batch of the Ad26.ZEBOV / MVA-BN-Filo vaccine, produced by Janssen / Johnson & Johnson, has arrived in Goma, Democratic Republic of Congo. The start of the study is scheduled for November 14th. Photograph by Gabriella Bianchi
Press release
Press release |
05 December 2019
Vaccines

MSF response to Gavi announcement on financing of global emergency stockpile of Ebola vaccine

3 min
The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece. Photograph by Anna Pantelia
Press release
Press release |
02 December 2019
Vaccines

US$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine

5 min
20-year-old Bagat Adshar, testing his blood sugar level with a glucometer in MSF’s diabetes clinic in Agok hospital. Photo by Musa Mahad
Press release
Press release |
14 November 2019
Diabetes

MSF response to the World Health Organization’s launch of its ‘prequalification’ programme for insulin

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury